Monopar Therapeutics (MNPR) Institutional Ownership $34.65 +0.14 (+0.41%) Closing price 04:00 PM EasternExtended Trading$34.24 -0.41 (-1.17%) As of 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)CurrentInstitutional OwnershipPercentage1.83%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$58.48MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.07M Get MNPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MNPR Institutional Buying and Selling by Quarter Monopar Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC10,357$377K0.0%N/A0.169% 5/16/2025 Goldman Sachs Group Inc.18,480$673K0.0%N/A0.302% 5/16/2025 ADAR1 Capital Management LLC100,774$3.67M0.7%-22.5%1.648% 5/15/2025 OMERS ADMINISTRATION Corp9,000$328K0.0%N/A0.147% 5/14/2025 Affinity Asset Advisors LLC62,000$2.26M0.2%N/A1.014% 5/14/2025 AlphaQuest LLC1,215$44K0.0%N/A0.020% 4/23/2025 Gerber LLC5,601$204K0.2%N/A0.092% 2/17/2025 Point72 Asset Management L.P.167,892$3.69M0.0%N/A2.752% 2/17/2025 Janus Henderson Group PLC1,046,899$23.44M0.0%N/A17.162% 2/14/2025 RA Capital Management L.P.511,207$11.25M0.1%N/A8.380% 2/14/2025 Adage Capital Partners GP L.L.C.599,195$13.18M0.0%N/A9.823% 2/13/2025 ADAR1 Capital Management LLC130,037$2.86M0.6%N/A2.132% 2/12/2025 Geode Capital Management LLC38,596$849K0.0%+174.4%0.633% 2/12/2025 JPMorgan Chase & Co.2,037$45K0.0%N/A0.033% 10/31/2023 Windsor Advisory Group LLC89,974$56K0.1%N/A0.635% 8/13/2021 Geode Capital Management LLC28,761$169K0.0%+9.0%0.229% 8/13/2021 Vanguard Group Inc.97,462$574K0.0%+116.2%0.775% 5/21/2021 Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/18/2021 Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/17/2021 Royal Bank of Canada9,130$57K0.0%N/A0.073% 5/12/2021 Northern Trust Corp36,001$223K0.0%-38.8%0.286% 5/12/2021 Geode Capital Management LLC26,394$163K0.0%N/A0.210% 5/7/2021BlackRock Inc.11,229$70K0.0%+108.3%0.089% (Data available from 1/1/2016 forward) MNPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNPR shares? During the previous two years, 14 institutional investors and hedge funds held shares of Monopar Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.44M), Adage Capital Partners GP L.L.C. ($13.18M), RA Capital Management L.P. ($11.25M), Point72 Asset Management L.P. ($3.69M), ADAR1 Capital Management LLC ($3.67M), Affinity Asset Advisors LLC ($2.26M), and Geode Capital Management LLC ($849K).Learn more on MNPR's institutional investors. What percentage of Monopar Therapeutics stock is owned by institutional investors? 1.83% of Monopar Therapeutics stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings. Which institutional investors have been buying Monopar Therapeutics stock? Of the 14 institutional investors that purchased Monopar Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.05M), Adage Capital Partners GP L.L.C. ($599.20K), RA Capital Management L.P. ($511.21K), Point72 Asset Management L.P. ($167.89K), ADAR1 Capital Management LLC ($130.04K), Windsor Advisory Group LLC ($89.97K), and Affinity Asset Advisors LLC ($62K). How much institutional buying is happening at Monopar Therapeutics? Institutional investors have bought a total of 2,678,424 shares in the last 24 months. This purchase volume represents approximately $58.76M in transactions. Which Monopar Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Monopar Therapeutics stock in the last 24 months: ADAR1 Capital Management LLC ($29.26K). How much institutional selling is happening at Monopar Therapeutics? Institutional investors have sold a total of 29,263 shares in the last 24 months. This volume of shares sold represents approximately $1.07M in transactions. Related Companies ArriVent BioPharma Major Shareholders Pharming Group Major Shareholders Immunome Major Shareholders Chimerix Major Shareholders Avid Bioservices Major Shareholders Gyre Therapeutics Major Shareholders Cogent Biosciences Major Shareholders Replimune Group Major Shareholders Cronos Group Major Shareholders Vir Biotechnology Major Shareholders This page (NASDAQ:MNPR) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
